Wednesday, April 21, 2010

Drug Channels Earnings Calendar: 2010Q1

Starting tomorrow, the big 3 drug wholesalers and the Big 3 Pharmacy Benefit Managers (PBMs) will begin reporting their latest financial results. These financial reports and accompanying conference calls provide invaluable insights into the strategies and economics of companies within U.S. drug channels.

As a service to Drug Channels readers, I'm providing the latest quarterly update of the upcoming calendar along with links to the earnings conference call webcasts for each company. If you don’t have time to listen to the calls, free transcripts show up on Seeking Alpha within a few days.

Pembroke Consulting retainer clients should feel free to contact me for post-game analysis on any of these reports. Gerson Lehrman Group customers can make a request via their GLG client representative.

BMO = Before Market Open
AMC = After Market Close

AmerisourceBergen (NYSE:ABC)
Thursday, April 22, 2010 (BMO)
Earnings Conference Call at 11:00 a.m. ET

Medco Health Solutions (NYSE:MHS)
Wednesday, April 28, 2010 (BMO)
Earnings Conference Call at 8:30 a.m. ET

Cardinal Health (NYSE:CAH)
Thursday, April 29, 2010 (BMO)
Earnings Conference Call at 8:30 a.m. ET

Express Scripts (NASDAQ:ESRX)
Thursday, April 29, 2010 (AMC)
Earnings Conference Call at 10:00 a.m. ET (no direct link yet)

McKesson (NYSE:MCK)
Monday, May 3, 2010 (AMC)
Earnings Conference Call at 5:00 p.m. ET

CVS Caremark (NYSE:CVS)
Tuesday, May 4, 2010 (BMO)
Earnings Conference Call TBD

The other two chain pharmacies report earnings in June.

Walgreen (NYSE:WAG)
Tuesday, June 22, 2010

Rite-Aid (NYSE:RAD)
Wednesday, June 23, 2010


FYI, many of my comments about drug wholesalers during the past quarter still apply. See Drug Wholesaler Earnings Preview: 2009Q4 and Is McKesson in the hunt for an EU acquisition?


  1. Thanks for the information on this. With all of the health care debate going on it seems like the drug industry has kind of been moved to the side without much talk about their profits. I work for an employer with a high deductible plan and our employees watch drug prices very closely. I recently published a site to enable better relationships with pharmacists and sharing of "cash price" on prescription drugs. The site is I was wondering where do you see pharma coming out on the recent law signed by Obama?

  2. From what I see and from what you have said in previous post, ESRX seems to be a much stronger stock than MCK. Looks like the PBM's are making plenty of profit.

  3. Per my policy, I have never said anything about the "strength" of any stock. Please review the disclaimer below.



Related Posts Plugin for WordPress, Blogger...